Developer docs
API playgroundTry for free, no card

Search company profiles

Gilero

Full company profile

uuid00037lv

Namestring
Gilero
Legal namestring
Gilero Group, LLC
Websiteurl
gilero.com
Company typeenum
Private
Founded yearint
2002
Descriptiontext

Gilero is a medical device contract development and manufacturing organization (CDMO) founded in 2002 and headquartered in Durham, North Carolina. The company provides end-to-end services spanning product design and engineering, clinical and small-batch manufacturing, electromechanical systems, human factors engineering, regulatory affairs, and contract manufacturing for medical devices, drug delivery systems, and combination products. Its service portfolio is organized around seven core areas: Design & Development, Clinical & Small Batch Builds, Electromechanical, Human Factors & Design, Regulatory Services, Contract Manufacturing, and a Global Manufacturing Network. The company serves medtech companies, pharmaceutical and drug delivery firms, and digital health/connected device companies requiring complex product development and scale-up support. Gilero is ISO 13485 certified, FDA registered, and operates in compliance with cGMPs, with manufacturing facilities totaling more than 300,000 square feet and ISO Class 7 and 8 cleanrooms across the U.S. (Durham, Pittsboro, Greensboro, Carlsbad, Chicago), Mexico (Tijuana), and Europe (Athlone, Ireland), with additional capacity accessed via its parent Sanner Group in Europe and Asia.

Gilero's revenue is generated primarily through professional services (engineering, design, regulatory consulting) and contract manufacturing (assembly, packaging, kitting, injection molding), with custom, project-based pricing typical of B2B CDMO engagements. The business operates exclusively through direct enterprise sales to medtech and pharmaceutical decision-makers, with no indirect channels or self-service model. The customer base includes named accounts such as Anutra Medical (buffered anesthetic delivery) and an ocular therapeutics company (intravitreal implant injection device), alongside unnamed Closed System Drug Transfer Device customers. The company is led by co-founder and CEO Ted Mosler and a management team with deep medical device and regulatory experience, including specialized VPs of Technical Operations, Manufacturing, Quality & Compliance, and Business Development.

On September 25, 2024, Gilero was acquired by Sanner Group, a German-headquartered global healthcare packaging and medical device CDMO backed by GHO Capital. The acquisition combined Sanner's 130-year market leadership and European/Asian manufacturing footprint with Gilero's North American design and manufacturing capabilities, positioning the combined business as a leading end-to-end provider across drug delivery, diagnostics, and medtech device sectors. Post-acquisition, Gilero continues to operate under its own brand, and in June 2025 launched a new 60,500-square-foot injection molding and pharmaceutical packaging facility in Greensboro, North Carolina—the first North American injection molding and pharma desiccant packaging site for Sanner Group.

Short descriptiontext

Gilero is a medical device CDMO providing end-to-end design, engineering, regulatory, and contract manufacturing services for medtech and pharmaceutical companies, operating globally as a subsidiary of Sanner Group since September 2024.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersDurham, United States
HQ citystring
Durham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices8 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device CDMO, drug delivery systems, contract manufacturing, medical device design, combination products
Industry3 codes
PRIMARYHLAGABAJ
Packaging, Labeling & Serialization (Clinical/Commercial) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAH
Sterile Fill-Finish & Aseptic Manufacturing CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAK
Clinical Trial Material (CTM) Manufacturing & Supply CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
NAICS code3 codes
  • Medical Equipment and Supplies Manufacturing3391
  • Surgical Appliance and Supplies Manufacturing339113
  • Pharmaceutical and Medicine Manufacturing32541
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Medical Device Contract Development and Manufacturing (CDMO)
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Contract Manufacturing Services
TypeProfessional Services
Description

Gilero generates revenue through contract manufacturing services for medical devices, including assembly, packaging, kitting, and injection molding. Manufacturing services are provided from facilities in the US, Mexico, Europe, and Asia.

gilero.com
2Design & Development Services
TypeProfessional Services
Description

Engineering and design services including product development, prototyping, testing, human factors engineering, and regulatory consulting. These professional services support clients from concept through commercialization.

gilero.com
3Combination Product Manufacturing
TypeHardware Sales
Description

Manufacturing of drug delivery systems and combination products, including drug handling, kitting, and packaging services for pharmaceutical and medical device combination products.

gilero.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Gilero is a medical device contract development and manufacturing organization (CDMO) that provides end-to-end services spanning design and development, clinical and small batch builds, electromechanical systems, human factors engineering, regulatory services, and contract manufacturing. The company partners with medtech and pharmaceutical companies to take medical devices and drug delivery systems from concept through commercialization, operating injection molding and cleanroom assembly facilities across North America, Europe, and Asia as part of the Sanner Group.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Reduced design-to-manufacturing friction through dedicated design transfer team
+1 more record
Product overview1 text field

Gilero is a medical device contract development and manufacturing organization (CDMO) offering end-to-end services from concept to global-scale production. The company operates as a single unified service offering that includes Design & Development, Clinical & Small Batch Builds, Electromechanical Systems, Human Factors & Design, Regulatory Services, Contract Manufacturing, and a Global Manufacturing Network. As part of the Sanner Group since September 2024, Gilero provides integrated design, development, assembly, packaging, and manufacturing services for medical devices, diagnostics, and drug delivery/combination products across facilities in North America, Europe, and Asia.

Product and service7 records
1Design & Development
CategoryDesign and Engineering Services
Description

Comprehensive medical device design and development services spanning concept to production, with subject matter expertise across drug delivery and diagnostic systems to anticipate design risks early. Aimed at medtech and pharmaceutical companies that need external engineering support to bring new medical devices to market.

2Clinical & Small Batch Builds
CategoryContract Manufacturing Services
Description

Tailored manufacturing services for companies developing products requiring clinical trials and small batch builds, with flexible manufacturing and specialized regulatory support for drug-led combination products. Designed for medtech and pharmaceutical clients moving from prototype to clinical-stage production.

3Electromechanical Systems Development
CategoryDesign and Engineering Services
Description

Development of electromechanical systems for medical devices, including both subsystems and fully integrated solutions that perform reliably and meet regulatory requirements. Targeted at medical device OEMs needing electronics, mechanics, and software integration.

4Human Factors & Design
CategoryDesign and Engineering Services
Description

Integration of human factors engineering into every stage of product development through robust risk analysis and usability testing, implementing design changes that mitigate context-dependent risks early in the design process. Targeted at medical device manufacturers needing FDA human factors compliance.

5Regulatory Services
CategoryRegulatory and Quality Services
Description

Expert regulatory guidance for devices at every stage of product development, managing regulatory communications, supporting submission processes, and maintaining long-term compliance for medical devices and combination products. Aimed at medtech and pharmaceutical companies navigating FDA, ISO 13485, and other regulatory pathways.

6Contract Manufacturing
CategoryContract Manufacturing Services
Description

Efficient, cost-effective manufacturing solutions with assembly and manufacturing processes for complex products that scale for production, including design transfer, injection molding, complex assembly, packaging, and kitting. Targeted at medical device OEMs requiring manufacturing partners for clinical and commercial volumes.

7Global Manufacturing Network
CategoryContract Manufacturing Services
Description

Scalable global manufacturing solutions with injection molding and cleanroom assembly facilities in the U.S., Mexico, Europe, and Asia to produce medical devices as finished goods. Designed for medtech and pharmaceutical companies needing multi-region manufacturing capacity and supply chain resilience.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-09-25
Description

Sanner Group, a leading global healthcare packaging and medical device CDMO headquartered in Germany, acquired Gilero on September 25, 2024. The acquisition positions the combined business as a leading provider of end-to-end services across drug delivery, diagnostics, and medtech device sectors. Gilero's capabilities in design, development, assembly, packaging, and contract manufacturing enhance Sanner's integrated offering, while Gilero gains access to Sanner's 130 years of market leadership, European and Asian manufacturing footprint, and desiccant packaging solutions.

Recent move12 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

One of the largest medical device CDMOs globally (Molex-owned), providing design, development, and contract manufacturing of drug delivery devices, combination products, and diagnostics. Highly comparable to Gilero across full device lifecycle services, injection molding, and combination product capability.

TypeDirect peer
Description

Global leader in injectable drug containment and delivery, supplying elastomeric closures, pre-filled syringe components, and drug delivery devices. Directly comparable as a primary CDMO partner to pharma for combination products and injectable delivery systems — Gilero's stated core focus.

TypeBroad incumbent
Description

Large diversified pharma services platform covering drug development, biologics, and drug delivery/auto-injector manufacturing. Overlaps with Gilero in combination product development and clinical-stage device manufacturing, but operates at significantly greater scale across the full pharma services stack.

TypeBroad incumbent
Description

Medical device outsource manufacturer offering design, development, and contract manufacturing of components and finished devices for cardiology, neurology, and surgical markets. Directly comparable business model to Gilero in medtech design-to-manufacturing outsourcing.

TypeBroad incumbent
Description

Division of Jabil providing manufacturing, design, and supply chain services for medical devices, drug delivery, and diagnostics. Comparable end-to-end CDMO offering but with the resources of a Fortune 500 contract manufacturer.

6Variavilla (Gerresheimer)
TypeBroad incumbent
Description

European-headquartered pharma and drug delivery packaging/CDMO with substantial plastic and glass primary packaging, autoinjector, and inhaler offerings. Overlaps with Gilero in drug delivery devices and combination product assembly.

7Recipharm
TypeBroad incumbent
Description

European CDMO providing contract development and manufacturing of pharmaceuticals and drug delivery devices. Comparable combination product and sterile manufacturing footprint, acquired by EQT-backed platform to scale pharma CDMO services.

TypeDirect peer
Description

Medical packaging CDMO specializing in thermoformed packaging, cleanroom manufacturing, and sterilization services for medical devices and pharma. Closely comparable in cleanroom-based contract manufacturing and packaging for medtech.

9Nipro Corporation
TypeBroad incumbent
Description

Japanese-headquartered medical device and pharma CDMO with global manufacturing for drug delivery, dialysis, and injection-related products. Comparable in injection molding and drug delivery device manufacturing across multiple jurisdictions.

TypeEmerging player
Description

Specialist micro-injection molder for medical and micro-miniature parts serving medtech and drug delivery customers. Comparable to Gilero's electromechanical and injection molding capabilities at the component level, though narrower in scope.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Gilero

Medical Device Contract Development and Manufacturing (CDMO)gilero.com

Gilero is a medical device CDMO providing end-to-end design, engineering, regulatory, and contract manufacturing services for medtech and pharmaceutical companies, operating globally as a subsidiary of Sanner Group since September 2024.

What Gilero does

Gilero is a medical device contract development and manufacturing organization (CDMO) founded in 2002 and headquartered in Durham, North Carolina. The company provides end-to-end services spanning product design and engineering, clinical and small-batch manufacturing, electromechanical systems, human factors engineering, regulatory affairs, and contract manufacturing for medical devices, drug delivery systems, and combination products. Its service portfolio is organized around seven core areas: Design & Development, Clinical & Small Batch Builds, Electromechanical, Human Factors & Design, Regulatory Services, Contract Manufacturing, and a Global Manufacturing Network. The company serves medtech companies, pharmaceutical and drug delivery firms, and digital health/connected device companies requiring complex product development and scale-up support. Gilero is ISO 13485 certified, FDA registered, and operates in compliance with cGMPs, with manufacturing facilities totaling more than 300,000 square feet and ISO Class 7 and 8 cleanrooms across the U.S. (Durham, Pittsboro, Greensboro, Carlsbad, Chicago), Mexico (Tijuana), and Europe (Athlone, Ireland), with additional capacity accessed via its parent Sanner Group in Europe and Asia.

Gilero's revenue is generated primarily through professional services (engineering, design, regulatory consulting) and contract manufacturing (assembly, packaging, kitting, injection molding), with custom, project-based pricing typical of B2B CDMO engagements. The business operates exclusively through direct enterprise sales to medtech and pharmaceutical decision-makers, with no indirect channels or self-service model. The customer base includes named accounts such as Anutra Medical (buffered anesthetic delivery) and an ocular therapeutics company (intravitreal implant injection device), alongside unnamed Closed System Drug Transfer Device customers. The company is led by co-founder and CEO Ted Mosler and a management team with deep medical device and regulatory experience, including specialized VPs of Technical Operations, Manufacturing, Quality & Compliance, and Business Development.

On September 25, 2024, Gilero was acquired by Sanner Group, a German-headquartered global healthcare packaging and medical device CDMO backed by GHO Capital. The acquisition combined Sanner's 130-year market leadership and European/Asian manufacturing footprint with Gilero's North American design and manufacturing capabilities, positioning the combined business as a leading end-to-end provider across drug delivery, diagnostics, and medtech device sectors. Post-acquisition, Gilero continues to operate under its own brand, and in June 2025 launched a new 60,500-square-foot injection molding and pharmaceutical packaging facility in Greensboro, North Carolina—the first North American injection molding and pharma desiccant packaging site for Sanner Group.

Gilero firmographics

Firmographics
Name
Gilero
Legal name
Gilero Group, LLC
Website
https://gilero.com
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
101–250 employees
Short description
Gilero is a medical device CDMO providing end-to-end design, engineering, regulatory, and contract manufacturing services for medtech and pharmaceutical companies, operating globally as a subsidiary of Sanner Group since September 2024.
Ownership category
akta.pro rank

Gilero industry classification

Industry
Product category
Medical Device Contract Development and Manufacturing (CDMO)
NAICS
Medical Equipment and Supplies Manufacturing (3391), Surgical Appliance and Supplies Manufacturing (339113), Pharmaceutical and Medicine Manufacturing (32541)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAGABAJ
Packaging, Labeling & Serialization (Clinical/Commercial) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAH
Sterile Fill-Finish & Aseptic Manufacturing CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAK
Clinical Trial Material (CTM) Manufacturing & Supply CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

  • Medical device CDMO
  • Drug delivery systems
  • Contract manufacturing
  • Medical device design
  • Combination products

Where Gilero is headquartered

Location

Headquarters

HQ city
Durham
HQ country
United States
HQ region
North America

Offices8 records

Markets served

Gilero business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

  1. Contract Manufacturing Services: Gilero generates revenue through contract manufacturing services for medical devices, including assembly, packaging, kitting, and injection molding. Manufacturing services are provided from facilities in the US, Mexico, Europe, and Asia.
  2. Design & Development Services: Engineering and design services including product development, prototyping, testing, human factors engineering, and regulatory consulting. These professional services support clients from concept through commercialization.
  3. Combination Product Manufacturing: Manufacturing of drug delivery systems and combination products, including drug handling, kitting, and packaging services for pharmaceutical and medical device combination products.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Gilero product offering

Product offering

Core offering

Gilero is a medical device contract development and manufacturing organization (CDMO) that provides end-to-end services spanning design and development, clinical and small batch builds, electromechanical systems, human factors engineering, regulatory services, and contract manufacturing. The company partners with medtech and pharmaceutical companies to take medical devices and drug delivery systems from concept through commercialization, operating injection molding and cleanroom assembly facilities across North America, Europe, and Asia as part of the Sanner Group.

Product overview

Gilero is a medical device contract development and manufacturing organization (CDMO) offering end-to-end services from concept to global-scale production. The company operates as a single unified service offering that includes Design & Development, Clinical & Small Batch Builds, Electromechanical Systems, Human Factors & Design, Regulatory Services, Contract Manufacturing, and a Global Manufacturing Network. As part of the Sanner Group since September 2024, Gilero provides integrated design, development, assembly, packaging, and manufacturing services for medical devices, diagnostics, and drug delivery/combination products across facilities in North America, Europe, and Asia.

Differentiator

Problem solved

Functional benefit

Products and services

  • Design & Development Comprehensive medical device design and development services spanning concept to production, with subject matter expertise across drug delivery and diagnostic systems to anticipate design risks early. Aimed at medtech and pharmaceutical companies that need external engineering support to bring new medical devices to market.
  • Clinical & Small Batch Builds Tailored manufacturing services for companies developing products requiring clinical trials and small batch builds, with flexible manufacturing and specialized regulatory support for drug-led combination products. Designed for medtech and pharmaceutical clients moving from prototype to clinical-stage production.
  • Electromechanical Systems Development Development of electromechanical systems for medical devices, including both subsystems and fully integrated solutions that perform reliably and meet regulatory requirements. Targeted at medical device OEMs needing electronics, mechanics, and software integration.
  • Human Factors & Design Integration of human factors engineering into every stage of product development through robust risk analysis and usability testing, implementing design changes that mitigate context-dependent risks early in the design process. Targeted at medical device manufacturers needing FDA human factors compliance.
  • Regulatory Services Expert regulatory guidance for devices at every stage of product development, managing regulatory communications, supporting submission processes, and maintaining long-term compliance for medical devices and combination products. Aimed at medtech and pharmaceutical companies navigating FDA, ISO 13485, and other regulatory pathways.
  • Contract Manufacturing Efficient, cost-effective manufacturing solutions with assembly and manufacturing processes for complex products that scale for production, including design transfer, injection molding, complex assembly, packaging, and kitting. Targeted at medical device OEMs requiring manufacturing partners for clinical and commercial volumes.
  • Global Manufacturing Network Scalable global manufacturing solutions with injection molding and cleanroom assembly facilities in the U.S., Mexico, Europe, and Asia to produce medical devices as finished goods. Designed for medtech and pharmaceutical companies needing multi-region manufacturing capacity and supply chain resilience.

Quantifiable outcome

  • Reduced design-to-manufacturing friction through dedicated design transfer team
  • +1 more outcomes

Companies that use Gilero

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Gilero technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Gilero partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Sanner GroupcoreStrategic or Co-development Partner · 25 September 2024Sanner Group, a leading global healthcare packaging and medical device CDMO headquartered in Germany, acquired Gilero on September 25, 2024. The acquisition positions the combined business as a leading provider of end-to-end services across drug delivery, diagnostics, and medtech device sectors. Gilero's capabilities in design, development, assembly, packaging, and contract manufacturing enhance Sanner's integrated offering, while Gilero gains access to Sanner's 130 years of market leadership, European and Asian manufacturing footprint, and desiccant packaging solutions.

Scale indicators6 records

Recent moves12 records

Expansion highlights5 records

Gilero competitors and assessment

Company assessment

Direct peers

  • Phillips-Medisize: One of the largest medical device CDMOs globally (Molex-owned), providing design, development, and contract manufacturing of drug delivery devices, combination products, and diagnostics. Highly comparable to Gilero across full device lifecycle services, injection molding, and combination product capability.
  • West Pharmaceutical Services: Global leader in injectable drug containment and delivery, supplying elastomeric closures, pre-filled syringe components, and drug delivery devices. Directly comparable as a primary CDMO partner to pharma for combination products and injectable delivery systems — Gilero's stated core focus.
  • Nelipak Corporation: Medical packaging CDMO specializing in thermoformed packaging, cleanroom manufacturing, and sterilization services for medical devices and pharma. Closely comparable in cleanroom-based contract manufacturing and packaging for medtech.

Broad incumbents

  • Catalent: Large diversified pharma services platform covering drug development, biologics, and drug delivery/auto-injector manufacturing. Overlaps with Gilero in combination product development and clinical-stage device manufacturing, but operates at significantly greater scale across the full pharma services stack.
  • Integer Holdings: Medical device outsource manufacturer offering design, development, and contract manufacturing of components and finished devices for cardiology, neurology, and surgical markets. Directly comparable business model to Gilero in medtech design-to-manufacturing outsourcing.
  • Jabil Healthcare: Division of Jabil providing manufacturing, design, and supply chain services for medical devices, drug delivery, and diagnostics. Comparable end-to-end CDMO offering but with the resources of a Fortune 500 contract manufacturer.
  • Variavilla (Gerresheimer): European-headquartered pharma and drug delivery packaging/CDMO with substantial plastic and glass primary packaging, autoinjector, and inhaler offerings. Overlaps with Gilero in drug delivery devices and combination product assembly.
  • Recipharm: European CDMO providing contract development and manufacturing of pharmaceuticals and drug delivery devices. Comparable combination product and sterile manufacturing footprint, acquired by EQT-backed platform to scale pharma CDMO services.
  • Nipro Corporation: Japanese-headquartered medical device and pharma CDMO with global manufacturing for drug delivery, dialysis, and injection-related products. Comparable in injection molding and drug delivery device manufacturing across multiple jurisdictions.

Emerging players

  • Accumold: Specialist micro-injection molder for medical and micro-miniature parts serving medtech and drug delivery customers. Comparable to Gilero's electromechanical and injection molding capabilities at the component level, though narrower in scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Gilero social profiles

Digital presence

Gilero compliance and trust

Trust signal

Compliance3 records

Gilero financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Gilero leadership team

Management profile

Number of profiles

Profiles12 records

Gilero funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Gilero M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gilero

What does Gilero do?

Gilero is a medical device contract development and manufacturing organization (CDMO) that provides end-to-end services spanning design and development, clinical and small batch builds, electromechanical systems, human factors engineering, regulatory services, and contract manufacturing. The company partners with medtech and pharmaceutical companies to take medical devices and drug delivery systems from concept through commercialization, operating injection molding and cleanroom assembly facilities across North America, Europe, and Asia as part of the Sanner Group.

Is Gilero a public or private company?

Gilero is a private company. It is classified as corporate owned and is currently operating.

When was Gilero founded?

Gilero was founded in 2002. It employs 101 to 250 people.

Where is Gilero based?

Gilero is headquartered in Durham, United States, in the North America region.

How does Gilero make money?

Three revenue lines are on record. Contract Manufacturing Services are the primary driver. The others are design & Development Services and combination Product Manufacturing.

Who are Gilero's main competitors?

Direct peers on record are Phillips-Medisize, West Pharmaceutical Services and Nelipak Corporation. Broad incumbents are Catalent, Integer Holdings, Jabil Healthcare, Variavilla (Gerresheimer), Recipharm and Nipro Corporation. Accumold is listed as an emerging player.

Does Gilero have an API?

No public API is recorded for Gilero.

What industry is Gilero in?

Gilero's product category is Medical Device Contract Development and Manufacturing (CDMO). Its primary akta.pro industry code is HLAGABAJ, Packaging, Labeling & Serialization (Clinical/Commercial) CDMO, with a secondary code of HLAGABAH, Sterile Fill-Finish & Aseptic Manufacturing CDMO. Its NAICS code is 3391 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireMedical Device Contract Manufacturing Market to Reach USD 191.40 Billion by 2032 Driven by Outsourcing Growth and Innovation in Smart Manufacturing | SNS InsiderAccording to market research by SNS Insider, the Medical Device Contract Manufacturing Market reached USD 69.75 billion in 2023 and is projected to grow to USD 191.40 billion by 2032, expanding at a CAGR of 11.89%, driven by outsourcing demand, advanced manufacturing technologies, and increasing device complexity. The Asia Pacific region led the market in 2023 with a 38.7% revenue share due to cost-effective manufacturing capabilities, while North America is expected to be the fastest-growing region as OEMs seek specialized expertise and regulatory compliance. Recent consolidation activity includes Arterex's acquisition of Italian medical device provider Phoenix S.r.l. in February 2025 and Sanner Group's acquisition of U.S.-based Gilero in September 2024.GileroContract ManufacturingGilero, a subsidiary of the Sanner Group, offers flexible contract manufacturing services for drug delivery systems, medical devices, and diagnostics across its global facilities. The company provides specialized capabilities including cleanroom injection molding, sterile barrier packaging, and regulatory support for FDA and international compliance.openPR.comAdvanced Wound Care Devices Market is expected to reach US$ 5.22 billion by 2033 | Gilero, Pensar Medical, Nexa Medical, Solventum, Medela, Alleva Medical Ltd., 3M, Talley GroupThe advanced wound care devices market reached US$ 3.80 billion in 2024 and is projected to reach US$ 5.22 billion by 2033, a CAGR of 4.3%. Growth is driven by technological innovations, including FDA-cleared products like NovaBone's Wound Matrix and Sky Medical's Geko device.GileroMedical Device Manufacturing ProcessGilero outlines seven strategic tips for successful medical device manufacturing, emphasizing the importance of early design integration, cost management, and selecting vertically integrated partners. The company highlights its capabilities in producing specialized devices such as autoinjectors and ocular drug delivery systems while adhering to strict regulatory guidelines like FDA cGMPs. These recommendations aim to help manufacturers achieve efficient production, faster time-to-market, and commercial success.Sanner-GroupSanner Group acquires Gilero to expand its global medical device offeringSanner Group has acquired Gilero, a medical device and drug delivery system CDMO, to expand its global end-to-end services in medtech and pharmaceuticals. This acquisition adds Gilero’s engineering and manufacturing capabilities across the United States, Mexico, and Ireland, strengthening Sanner’s footprint in key biopharma hubs. The deal aims to enhance vertical integration and mitigate supply chain issues by providing local production solutions for customers.BioSpaceKORU Medical Announces Collaboration With Gilero to Accelerate InnovationKORU Medical announced a collaboration with Gilero to accelerate innovation in its home infusion products. The partnership aims to expand KORU's at-home infusion portfolio, with Gilero serving as the preferred contract engineering firm. The collaboration is part of KORU's strategic focus on innovation as it expands its product line.PR NewswireSCONE Medical Solutions Inc. Receives Emergency Use Authorization for Self-Contained Negative Pressure EnvironmentSCONE Medical Solutions Inc. announced that its Self-Contained Negative Pressure Environment (SCONE™) device received FDA Emergency Use Authorization and is available for sale to US hospitals beginning December 2020. The device uses negative pressure technology to create barrier protection for healthcare workers against infectious aerosol exposure, addressing the heightened risks during the ongoing COVID-19 pandemic. SCONE partnered with Gilero for product design, development, and manufacturing, and with Mayo Clinic for clinical support, completing development in approximately four months.PR NewswireGilero Opens New Design Center in Southern CaliforniaGilero, a contract design, development and manufacturing firm specializing in medical and drug delivery devices, has opened a new Design Center in Carlsbad, California. The facility, the company's second Design Center, will provide engineering services including human factors research, concept development, prototyping, testing and regulatory support to better serve existing customers and foster new industry relationships. This expansion represents part of Gilero's broader planned growth efforts to increase its West Coast presence and improve responsiveness to customers in the region.